Psychology & Intimacy A major Alzheimer’s risk gene may shrink brain cells years before symptoms October 6, 2026 Rebecca Shoemaker For decades, medical researchers have understood that genetics play a profound role in the development of Alzheimer’s disease, a progressive neurodegenerative disorder that currently affects millions of individuals globally. Among…
Psychology & Intimacy Beyond Plaques and Tangles: Scientists Uncover 3D Genome Disruption as a New Frontier in Alzheimer’s Disease Research October 5, 2026 Rebecca Shoemaker In a breakthrough that promises to reshape the landscape of neurodegenerative research, an interdisciplinary team of scientists from Carnegie Mellon University, the University of Pittsburgh School of Medicine, and the…
Sexual Health & Medical Wellness Common Respiratory Bacterium Linked to Alzheimer’s Disease Progression Through Ocular and Brain Infection October 2, 2026 Susilo Ahmad A groundbreaking study conducted by researchers at Cedars-Sinai has identified a potentially critical link between a common respiratory bacterium and the progression of Alzheimer’s disease. Published in the journal Nature…
Psychology & Intimacy A New Frontier in Neuropharmacology: ETH Zurich Researchers Develop Compound 10 to Disrupt the Cellular Mechanisms of Alzheimer’s Disease October 1, 2026 Rebecca Shoemaker The global scientific community has long grappled with the profound complexities of neurodegenerative disorders, among which Alzheimer’s disease stands as one of the most formidable challenges in modern medicine. Despite…
Psychology & Intimacy A major Alzheimer’s risk gene may shrink brain cells years before symptoms September 29, 2026 Rebecca Shoemaker Millions of individuals worldwide carry APOE4, widely recognized by the scientific community as the single strongest genetic risk factor for the development of late-onset Alzheimer’s disease. Despite its prevalence—affecting approximately…
Psychology & Intimacy Beyond Amyloid and Tau: Multi-Institutional Research Uncovers 3D Genome Reorganization in Alzheimer’s Disease Brain Cells September 28, 2026 Rebecca Shoemaker A collaborative team of researchers hailing from Carnegie Mellon University’s School of Computer Science, the University of Pittsburgh School of Medicine, and the University of Washington has published groundbreaking findings…
Psychology & Intimacy New ETH Zurich Alzheimer’s Treatment Target and Compound 10 Show Promise in Preclinical Studies September 21, 2026 Rebecca Shoemaker The global scientific community continues to grapple with one of modern medicine’s most elusive challenges: halting the relentless progression of Alzheimer’s disease. Amid decades of incremental progress and numerous clinical…
Psychology & Intimacy Beyond Amyloid and Tau: Multidisciplinary Research Unlocks the Three-Dimensional Genome Architecture of Alzheimer’s Disease September 21, 2026 Rebecca Shoemaker Researchers across multiple premier academic institutions have unveiled a groundbreaking perspective on Alzheimer’s disease, identifying a previously underexplored feature of its molecular pathology that could fundamentally reshape future therapeutic development.…
Psychology & Intimacy New Research Reveals How APOE4 Triggers Early Brain Changes and Identifies Potential Pathway for Alzheimer’s Reversal September 20, 2026 Rebecca Shoemaker Millions of individuals worldwide carry APOE4, widely recognized as the most potent genetic risk factor for the development of late-onset Alzheimer’s disease. For decades, the precise biological mechanisms by which…
Human Sexuality Research & Journals New Alzheimer’s disease diagnostics and psychological clinical perspectives September 17, 2026 Lina Irawan The landscape of Alzheimer’s disease (AD) management is undergoing a profound paradigm shift. Driven by breakthroughs in blood-based biomarkers (BBMs) such as plasma phosphorylated tau 217 (p-tau217), clinicians can now…
